Skip to main content
SpringerLink
Log in

Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Anti-pyruvate dehydrogenase (PDH) antibodies were determined in 1451 sera of patients with primary biliary cirrhosis (PBC) and several autoimmune rheumatic conditions by ELISA and immunoblotting. They were detected in sera of 93% of the patients with PBC (179 of 192 patients) in 60 of 277 (22%) patients with Sjogren's syndrome (SjS), 34 of 437 (8%) patients with scleroderma, 33 of 191 patients with SLE (17%), and 5 of 55 (10%) patients with rheumatoid arthritis (RA) but in none of the patients with polymyositis or the antiphospholipid syndrome. The ELISA studies were confirmed by immunoblots showing binding of autoimmune rheumatic sera to the same epitope (74 kd) of mitochondria that the PBC sera reacted with. The identical binding characteristics were also confirmed by protein competition assays with purified PDH. In 4 of 53 patients with SjS who were positive for anti-PDH, high titers as in PBC were detected. The anti-PDH antibodies in Sjogren's patients were associated with deranged liver function tests and extraglandular features but did not correlate with any other non-organ-specific antibody. Follow-up studies confirmed the association of the emergence of anti-PDH antibodies with defects in liver function tests. The antibodies were more prevalent in SLE and RA when they were associated with Sjogren's syndrome (30 and 18.8%, respectively). Among patients with different forms of scleroderma, anti-PDH antibodies were noted in subjects with systemic sclerosis, morphea, and Raynaud's phenomenon. The incidence was much more significant among patients with calcinosis, Raynaud's, esophageal dysmotility, sclerosis, and telangiectasia (CREST) (8/34), in whom antibodies were detected in 5 who had already developed PBC. The relationship among anti-PDH antibodies, PBC, and development of other autoimmune rheumatic conditions is discussed. It is proposed that the early detection of anti-PDH antibodies in patients with rheumatic conditions may predict the future development of PBC. This observation may have therapeutic implications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. James SP, Hoofnagle JH, Stroker W, James EA: Primary biliary cirrhosis: A model of autoimmune disease. Ann Intern Med 99:512–550, 1983

    Google Scholar 

  2. Kaplan MM: Primary biliary cirrhosis. N Engl J Med 316:521–528, 1987

    Google Scholar 

  3. Gershwin ME, Coppel RI, Mackay IR: Primary biliary cirrhosis and mitochondrial autoantigens-insights from molecular biology. Hepatology 8:147–151, 1988

    Google Scholar 

  4. Zurgil N, Konikof F, Bakimer R, Slor H, Shoenfeld Y: Detection of antimitochondrial antibodies: Characterization by enzyme immunoassay and immunoblotting. Autoimmunity 4:289–297, 1989

    Google Scholar 

  5. Gershwin ME, Mackay IR, Sturgess A,et al. Identification and specificity of cDNA encoding the 70 Kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138:3525–3531, 1988

    Google Scholar 

  6. Surh CD, Roche TE, Danher DJ,et al. Antimitochondrial autoantibodies in primary biliary cirrhosis recognize cross reactive epitopes on protein x and dihydrolipoamide acyltransferase of pyruvate dehydrogenases complex. Hepatology 10:127–133, 1989

    Google Scholar 

  7. Fregeau DR, Davis PA, Danner DJ,et al. Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferases and inhibit enzyme function of the branched chain & ketoacid dehydrogenases complex. J Immunol 142:3815–3822, 1989

    Google Scholar 

  8. Penner E, Reichlin M: Primary biliary cirrhosis associated with Sjogren's syndrome: Evidence for circulating and tissue deposited Ro/anti-Ro immune complexes. Arth Rheumatol 25:1250–1253, 1982

    Google Scholar 

  9. Alarcon-Segovia D, Diaz-Jouanen E, Fishbein E: Features of Sjogren's syndrome in primary biliary cirrhosis. Ann Intern Med 79:31–36, 1973

    Google Scholar 

  10. Weiss P, Shoenfeld Y: Primary biliary cirrhosis is a multisystem disorder. Ann Med Interne 142:283–287, 1991

    Google Scholar 

  11. Hall S, Axetsen PH, Larson DE, Bunch TW: Systemic lupus erythematosus developing in patients with primary biliary cirrhosis. Ann Intern Med 100:388–389, 1984

    Google Scholar 

  12. Gupta RC, Seibold JR, Krishnan MR, Steigerwald JC: Precipitating autoantibodies to mitochondrial proteins in progressive systemic sclerosis. Clin Exp Immunol 57:68–76, 1984

    Google Scholar 

  13. Alderuccio F, Toh BH, Barnett AJ, Pedersen JS: Identification and characterization of mitochondria autoantigens in progressive systemic sclerosis: identity with the 72,000 dalton autoantigen in primary biliary cirrhosis. J Immunol 137:1855–1859, 1986

    Google Scholar 

  14. Murray-Lyon IM, Thompson RPH, Ansell ID, Williams R: Scleroderma and primary biliary cirrhosis. Br Med J 3:258–259, 1970

    Google Scholar 

  15. Reynolds TB, Denison EK, Frankl HD, Lieberman FL, Peters RL: Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. Am J Med 50:302–312, 1971

    Google Scholar 

  16. Morgan MY: Primary biliary cirrhosis, scleroderma and keratoconjunctivitis sicca. Proc Roy Soc Med 66:12–56, 1973

    Google Scholar 

  17. Uhl GS, Baldwin JL, Arnett FC: Primary biliary cirrhosis in systemic sclerosis (scleroderma) and polymyositis. Johns Hopkins Med J 135:191–198, 1974

    Google Scholar 

  18. Stanley CJ, Perham RN: Purification of 2-oxo-acid dehydrogenase multienzyme complexes from ox heart by a new method. Biochem J 191:147–154, 1980

    Google Scholar 

  19. Moutsopoulos HM, Webber BL, Vlagopoulos TP, Chused TM, Decker JL: Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med 66:733–736, 1979

    Google Scholar 

  20. Tarpley TM, Anderson LG, White GL: Minor salivary gland involvement in Sjogren's syndrome. Oral Surg 37:64–74, 1974

    Google Scholar 

  21. Tzioufas AG, Manoussakis MN, Costello R, Silis M, Papadopoulos NM, Moutsopoulos HM: Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjogren's syndrome. Arth Rheum 29:1098–1104, 1986

    Google Scholar 

  22. Schumacher HR (ed): Primer on the Rheumatic Diseases Criteria for the Diagnosis of the Rheumatic Diseases. 9th ed. Atlanta, GA, Arthritis Foundation, 1988, pp 316–320

    Google Scholar 

  23. Asherson RA, Khamashta M, Ordi-Ros J,et al. The “primary” antiphospholipid syndrome: Major clinical and serological features. Medicine 68:366–374, 1989

    Google Scholar 

  24. Laemmli UK: Cleavage of structural proteins during assembly of the head of bacteriophage. Nature 227:680–685, 1970

    Google Scholar 

  25. Zurgil N, Bakimer R, Kaplan N, Youinou P, Shoenfeld Y: Anti-pyruvate dehydrogenase autoantibodies in primary biliary cirrhosis. J Clin Immunol 11:239–245, 1991

    Google Scholar 

  26. Shoenfeld Y, Isenberg DA (eds): The Mosaic of Autoimmunity. Amsterdam, Elsevier, 1989, pp 1–520

    Google Scholar 

  27. Wiesner RH, Ludwig J, Limdor K,et al. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med 322:1419–1424, 1990

    Google Scholar 

  28. Poupon RE, Eschwege E, Poupon P: Ursodeoxycholic acid for the treatment of primary biliary cirrhosis: Interim analysis of a double-blind multi centre randomized trial. J Hepatol 11:16–21, 1990

    Google Scholar 

  29. Mitchson HC, Bassendine MF, Malcolm AJ, Watson AJ, Recorol CO, James OFW: A pilot double-blind controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: Hepatic improvement but greater bone loss. Hepatology 10:420–429, 1989

    Google Scholar 

  30. August PJ. Primary biliary cirrhosis and scleroderma. Proc Roy Soc Med 67:1238–1239, 1974

    Google Scholar 

  31. Miller F, Bernard L, Soterakis J, d'Angelo W: Primary biliary cirrhosis and scleroderma. Arch Pathol Lab Med 103:505–509, 1979

    Google Scholar 

  32. Diaz PA, Schuman BM: Primary biliary cirrhosis with systemic sclerosis associated with Raynaud's phenomenon and telangiectasia. Gastroenterology 64:183–184, 1973

    Google Scholar 

  33. Medd WL, Sodhi HS: Primary biliary cirrhosis and scleroderma variant: A case presentation. J Maine Med Assoc 71:308–311, 1980

    Google Scholar 

  34. Diederichesen H, Clausen C, Lundborg CJ: Asymptomatic primary biliary cirrhosis associated with Raynaud's phenomenon, sclerodactyly and telangiectasia. Dan Med Bull 28:212–215, 1981

    Google Scholar 

  35. O'Brien ST, Eddy WM, Krawitt EL: Primary biliary cirrhosis associated with scleroderma. Gastroenterology 62:11–124, 1972

    Google Scholar 

  36. Powell FC, Schroeter AL, Dickson ER: Primary biliary cirrhosis and the CREST syndrome: A report of 22 cases. Q J Med 237:75–82, 1987

    Google Scholar 

  37. Clarke AK, Galbraith RM, Hamilton EBD, Williams R: Rheumatic disorders in primary biliary cirrhosis. Ann Rheum Dis 37:42–47, 1978

    Google Scholar 

  38. Alarcon-Segovia D, Diaz-Jouanen E, Fishbein E: Features of Sjogren's syndrome in primary biliary cirrhosis. Clin Intern Med 79:31–36, 1973

    Google Scholar 

  39. Hansen BU, Lindgren S, Eriksson S, Henricsson V, Larsson A, Monthrope R, Warfvinge G: Clinical and immunological features of Sjogren's syndrome in patients with PBC with emphasis on focal sialadenitis. Acta Med Scand 244:611–619, 1988

    Google Scholar 

  40. Culp KS, Fleming CR, Duffy J, Baldus WP, Dickson ER: Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 57:365–370, 1982

    Google Scholar 

  41. Tincani A, Meroni PL, Brucato A, Zanussi C, Allegri F, Mantelli P, Cattaneo R, Balestrieri G: Anti-phospholipid and anti-mitochondrial type M5 antibodies in SLE. Clin Exp Rheum 3:321–324, 1985

    Google Scholar 

  42. Norberg R, Gardlund B, Thorstensson R, Lidman K: Further immunological studies of sera containing anti-mitochondrial antibodies type M5. Clin Exp Immunol 58:639–643, 1984

    Google Scholar 

  43. Meroni PL, Harris EN, Brucato A, Tincani A, Barcellini W, Vismara A, Balestrieri G, Hughes GRV, Zanussi C: Anti-mitochondrial type M5 and anti-cardiolipin antibodies in autoimmune disorders: Studies on their association and cross-reactivity. Clin Exp Immunol 67:484–491, 1987

    Google Scholar 

  44. Miller MH, Aguaf N, Cyna L, Homberg JC, Kahn MF, Pyckuwaert A: Anti-mitochondrial type 5 antibodies and anti-cardiolipin antibodies in SLE and autoimmune diseases. Clin Exp Immunol 69:485–492, 1987

    Google Scholar 

  45. Miller MH, Murowitz MB, Gladman DD, Blends LM: The liver in SLE. Q J Med 211:401–407, 1984

    Google Scholar 

  46. Mouritsen S, Demant E, Permin H, Wilk A: High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases. Clin Exp Immunol 60:68–76, 1986

    Google Scholar 

  47. McHugh NJ, James IE, Fairburn K, Maddison PJ: Autoantibodies to mitochondrial and centromer antigens in primary biliary cirrhosis and systemic sclerosis. Clin Exp Immunol 81:244–249, 1990

    Google Scholar 

  48. Fregeau DR, Leung PSC, Coppel RL, McNeilage LJ, Medsger TA, Gershwin ME: Autoantibodies to mitochondria in systemic sclerosis. Arth Rheum 31:386–392, 1988

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine B, Sheba Medical Center, 52621, Tel-Hashomer, Israel

    N. Zurgil, R. Bakimer & Y. Shoenfeld

  2. BioHytech Ltd., D. Friedman 10, Ramat-Gan, Israel

    N. Zurgil

  3. Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina, Greece

    H. M. Moutsopoulos & A. G. Tzioufas

  4. Laboratoire D'Immunologie Center, Hospital Regional et Universitaire de Brest, Brest, France

    P. Youinou

  5. Bloomsbury Rheumatology Unit, University College, and Middlesex Hospital, School of Medicine, London, England

    D. A. Isenberg

  6. Instituto Arnaldo Viera Carvalho, Sāo Paulo, Brazil

    M. Scheinberg

  7. University Medical Center Department of Rheumatology, Lublijana, Slovenia, Yugoslavia

    B. Rozman

  8. University Medical Centre, Munchen, Germany

    C. Luderschmidt

  9. Istituto di Clinica Medica I, University of Milan Department of Medicine, Milano, Italy

    P. L. Meroni

  10. Gastroenterology Service, New England Medical Center Hospitals, Boston, Massachusetts

    M. M. Kaplan

Authors
  1. N. Zurgil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Bakimer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. M. Moutsopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. G. Tzioufas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Youinou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. A. Isenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Scheinberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T. Kveder
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. B. Rozman
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C. Luderschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. P. L. Meroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. M. M. Kaplan
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Y. Shoenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zurgil, N., Bakimer, R., Moutsopoulos, H.M. et al. Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases. J Clin Immunol 12, 201–209 (1992). https://doi.org/10.1007/BF00918090

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00918090

Key words

Search

Navigation